Experts
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on CSL.
RELATED STOCKHEAD STORIES
Experts
ScoPo’s powerplays: Searching for gems as healthcare sector languishes
News
ScoPo’s powerplays: Morgans’ healthcare picks for 2021
Experts
Money Talks: Here are Barclay Pearce’s top 2021 ASX picks
Director Trades
Directors’ Trades: These ASX directors went a-share buying as part of their Christmas shopping
News
Experts give us their top stock picks for 2021
Health & Biotech
CSL dips after abandoning University of Queensland COVID vaccine trial
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
The ASX biotech companies that lost puff on Pfizer vaccine news
Health & Biotech
Here’s what the ASX health sector must do to rival the tech sector
Experts
ScoPo’s health powerplays: ‘We’re buying any pullbacks’
Health & Biotech
COVID has opened up potentially lucrative opportunities for these Aussie microcaps
News
CSL in $1.7bn deal to make two COVID-19 vaccines for Aussies
Experts
Scopo’s powerplays: Investors love a result, until they don’t
Health & Biotech
University of Queensland’s COVID-19 vaccine becomes 32nd globally to head into human trials
Experts
Scopo’s health powerplays: Markets are getting back to normal
Health & Biotech
COVID-19 adds $9bn to top four ASX health stocks
Experts
